Kidney health: Common constipation drug shows promise in protecting kidneys from decline

A common constipation drug, lubiprostone, shows remarkable potential in slowing kidney function decline for chronic kidney disease (CKD) patients. Research indicates it reshapes gut bacteria, boosting a compound that enhances cellular energy and resilience in kidney cells. This discovery offers a novel, gut-focused approach to protecting kidneys, a significant development given CKD’s rising global impact.